Background:Pre-eclampsia (PE), a complex, multisystem, pregnancy-associated hypertensive disorder, typically developing after the 20thweek of gestation, that
complicates 2% - 8% of pregnancies, is a leading cause of neonatal and maternal mortality and morbidity.Aim of the Work: To identify different factors predicting
transformation of non-severe pre-eclampsia in to pre-eclampsia with severe features.?Patients
and Methods:This
prospective cohort study was conducted at tertiary care hospital at Ain Shams
University hospitals from June 2021 till January 2022 and performed on total of
100 patients who diagnosed as non-severe pre-eclampsia after exclusion of
severity features.Results: The current study revealed that transformation to severe pre-eclampsia occurred in 33% of the studied cases. Body mass index
(BMI), past and family histories of preeclampsia statistically were
significantly higher in cases transformed into preeclampsia with severe
features. Admission blood pressure, albumin dipstick, Oligohydramnios and IUGR
statistically were significantly higher in cases with transformation from
non-severe pre-eclampsia into pre-eclampsia with severe features.Platelet count statistically was significantly lower
in cases with transformation from
References
[1]
Chesley, L. (2015) Chesley’s Hypertensive Disorders in Pregnancy. 4th Edition, Elsevier.
[2]
Moussa, H.N., Arian, S.E. and Sibai, B.M. (2014) Management of Hypertensive Disorders in Pregnancy. Women’s Health Journal, 10, 385-404.
https://doi.org/10.2217/WHE.14.32
[3]
Say, L., Chou, D. and Gemmill, A (2014) Global Causes of Maternal Death: A WHO Systematic Analysis. The Lancet Global Health, 2, e323-e333.
https://doi.org/10.1016/S2214-109X(14)70227-X
[4]
Bokslag, A., van Weissenbruch, M., Mol, B.W. and de Groot, C.J.M. (2016) Preeclampsia: Short and Long-Term Consequences for Mother and Neonate. Early Human Development, 102, 47-50. https://doi.org/10.1016/j.earlhumdev.2016.09.007
[5]
American College of Obstetricians and Gynecologists (ACOG) (2019) ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstetrics and Gynecology, 133, e26-e50. https://doi.org/10.1097/AOG.0000000000003020
[6]
Giannakou, K. (2021) Prediction of Pre-Eclampsia. Obstetric Medicine, 14, 220-224.
https://doi.org/10.1177/1753495X20984015
[7]
North, R.A., McCowan, L.M. and Dekker, G.A. (2011) Clinical Risk Prediction for Pre-Eclampsia in Nulliparous Women: Development of Model in International Prospective Cohort. BMJ, 342, d1875. https://doi.org/10.1136/bmj.d1875
[8]
Snydal, S. (2014) Major Changes in Diagnosis and Management of Preeclampsia. Journal of Midwifery & Women’s Health, 59, 596-605.
https://doi.org/10.1111/jmwh.12260
[9]
Poon, L.C., Kametas, N.A., Chelemen, T., Leal, A. and Nicolaides, K.H. (2010) Maternal Risk Factors for Hypertensive Disorders in Pregnancy: Amultivariate Approach. Journal of Human Hypertension, 104, 104-110.
https://doi.org/10.1038/jhh.2009.45
[10]
Myers, J.E., Kenny, L.C., McCowan, L.M., Chan, E.H., Dekker, G.A., Poston, L., Simpson, N.A., North, R.A. and SCOPE Consortium (2013) Angiogenic Factors Combined with Clinical Risk Factors to Predict Preterm Pre-Eclampsia in Nulliparous Women: A Predictive Test Accuracy Study. BJOG, 120, 1215-1223.
https://doi.org/10.1111/1471-0528.12195